Central International Law Firm
首页 >新闻和资料 > 业务通信和新闻稿
•  Report on the Korean Intellectual Property Office’s 2021 Performance in Regulating Counterfeit Goods
•  Patent Court Decision 2020Hu4129, determining whether a medicinal product can be applicable for the Patent Term Extension application that is allowed for products manufactured w
•  Case on Establishment and Cancellation of Confessions in Patent Infringement Lawsuits (Supreme Court Decision No. 2019Da277751, rendered on January 27, 2022)
•  Korean Supreme Court decision as to whether a prior art cited against a patent invention which lacks novelty was publicly performed (Supreme Court Case No. 2021Hu10732 decided
•  Key Revisions to the 2021 Korean Trademark Act(Amended on October 19, 2021 and enforced on April 20, 2022)
•  Key Revisions to the 2021 Korean Design Protection Act
•  Coronavirus vaccine-related patent application newly designated as a subject eligible for expedited examination(Revision of the Enforcement Decree of the Korean Patent Act (KP
•  Revised Korean Patent Act effective from April 20, 2022
•  (Amended on October 19, 2021 and enforced on April 20, 2022)
•  The Supreme Court judged that if a Final Rejection does not mention a particular ground for rejection, the applicant must be informed of the ground for rejection in order for suc
◀◀  1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10   ▶▶

COPYRIGHTⓒ2011 CENTRAL Intellectual Property & Law. ALL RIGHTS RESERVED
地址: 大韓民国 首尔特别市钟路区钟路5街68 KOREAN RE大厦5楼 (03151) CENTRAL INTELLECTUAL PROPERTY & LAW